Kavalactone product
AssigneeHerbal Science, LLC
InventorsRobert Gow, John Pierce, Brian Pierce, William Birdsall
Life of this patent
Estimating the term…
Abstract
The present invention is a method for enhancing the efficacy of an active ingredient in a human comprising: administering to said human a product comprising: a kavalactone component and an active ingredient, wherein said active ingredient is selected from the group consisting of a therapeutic, a pharmaceutical, a nutraceutical and a botanical, and wherein said kavalactone component comprises a methysticin component, a dihydromethysticin component, a desmethoxyyangonin component, a yangonin component, a dihydrokavain component, and a kavain component, and wherein said kavalactone component is between about 0.1% to about 75%, by mass, of said product.
Claims12
A method for enhancing the efficacy of an active ingredient in a human comprising, administering to said human in need thereof a product comprising;
- a kavalactone component and an active ingredient,
- wherein the kavalactone component comprises, by mass, less than about 15% of a combination of methysticin and dihydromethysticin, less than about 8% of a combination of yangonin and desmethoxyyangonin, and greater than about 70% of a combination of kavain and dihydrokavain,
- wherein the kavalactone component is between about 0.1% to about 75% by mass of said product, and
- wherein the active ingredient is methylsulfonylmethane, acetylsalicylic acid, NSAIDSs, ibuprofen, acetaminophen, nitrous oxide, benzocaine, procaine, lidocaine, anesthetics, halothane, thorazine, vesprin, prolixin, opoid analgesics and antagonists, morphine, codeine or oxycodone.
Dependencies are inferred from the claim text.